Topical agent therapy for prevention and treatment of radiodermatitis: a meta-analysis
- 12 October 2012
- journal article
- research article
- Published by Springer Science and Business Media LLC in Supportive Care in Cancer
- Vol. 21 (4), 1025-1031
- https://doi.org/10.1007/s00520-012-1622-5
Abstract
Radiodermatitis (RD) is a common side effect during radiotherapy. Various topical agents have been tried to be applied on RD. However, the efficiency of topical agents applied on radiotherapy is still uncertain. This study aims to assess the efficiency of the topical agents in the prevention and treatment of RD. The Cochrane Central Register of Controlled Trials, Pubmed, and Medline were searched for relevant reports. Quantitative analysis was carried out to evaluate the efficiency of topical agents in the prevention and treatment of RD. Twenty reports involving 3,098 patients were included: 2,406 patients for prophylactic trials and 692 for treatment trials, respectively. For prophylactic trials, primary meta-analysis indicated that using topical agents could not reduce the incidence of grade 2 and higher RD (P = 0.128, RR = 0.90, 95 % CI = 0.78–1.03) with a high heterogeneity (P = 0.000, I 2 = 71.5 %). In subgroup analyses, heterogeneity disappeared by excluding reports with low Jadad score (≤3) (P = 0.292, I 2 = 15.2 %), and still no significant difference was found between the topical agent group and control group (P = 0.625, RR = 0.98, 95 % CI = 0.89–1.07). In addition, for treatment trials, topical agents failed to increase the incidence of wound healing (P = 0.784, RR = 1.01, 95 % CI = 0.92–1.12) with a high heterogeneity (P = 0.067, I 2 = 51.5 %). Topical agents could not prevent or treat RD effectively. New type of agents should be developed to improve the efficiency based on the pathophysiology of RD.Keywords
This publication has 41 references indexed in Scilit:
- Mometasone Furoate Effect on Acute Skin Toxicity in Breast Cancer Patients Receiving Radiotherapy: A Phase III Double-Blind, Randomized Trial From the North Central Cancer Treatment Group N06C4International Journal of Radiation Oncology*Biology*Physics, 2010
- Traitement et prévention des radiodermites aiguësCancer/Radiothérapie, 2010
- Wound repair at a glanceJournal of Cell Science, 2009
- Topical betamethasone for prevention of radiation dermatitisIndian Journal of Dermatology, Venereology and Leprology, 2007
- The Validity of Skin Care Protocols Followed by Women With Breast Cancer Receiving External RadiationClinical Journal of Oncology Nursing, 2006
- Phase III Trial of an Emulsion Containing Trolamine for the Prevention of Radiation Dermatitis in Patients With Advanced Squamous Cell Carcinoma of the Head and Neck: Results of Radiation Therapy Oncology Group Trial 99-13Journal of Clinical Oncology, 2006
- Radiation dermatitis: Clinical presentation, pathophysiology, and treatment 2006Journal of the American Academy of Dermatology, 2006
- Prevention and Treatment of Acute Radiation Dermatitis: A Literature ReviewOncology Nursing Forum, 2004
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996